Lars Ole Gerlach

637 total citations
10 papers, 515 citations indexed

About

Lars Ole Gerlach is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Lars Ole Gerlach has authored 10 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Lars Ole Gerlach's work include Immunotherapy and Immune Responses (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Cell Adhesion Molecules Research (2 papers). Lars Ole Gerlach is often cited by papers focused on Immunotherapy and Immune Responses (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Cell Adhesion Molecules Research (2 papers). Lars Ole Gerlach collaborates with scholars based in Denmark, Germany and United States. Lars Ole Gerlach's co-authors include Gary Bridger, Thue W. Schwartz, Renato T. Skerlj, Mette M. Rosenkilde, Janus S. Jakobsen, Kasper P. Jensen, Ulf Ryde, Karl Kunzelmann, R. Greger and Trond Ulven and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Oncogene.

In The Last Decade

Lars Ole Gerlach

10 papers receiving 496 citations

Peers

Lars Ole Gerlach

ONCOL

IMMUN

CMN

VIROL

Amos Bodner United States

Stefanie Thiele Denmark

Danny J. Scholten Netherlands

Natalya V. Belkina United States

Deni Taleski Australia

Joseph R. Woska United States

Sonia Troiani Italy

Larry E. Kahn United States

Barbara‐Jean Bormann United States

J C Kallestad United States

Amos Bodner United States

Lars Ole Gerlach

328 ×1.2

90 ×0.4

ONCOL

79 ×0.5

IMMUN

76 ×1.0

CMN

58 ×0.9

VIROL

Citations per year, relative to Lars Ole Gerlach Lars Ole Gerlach (= 1×) peers Amos Bodner

Countries citing papers authored by Lars Ole Gerlach

Since Specialization

Citations

This map shows the geographic impact of Lars Ole Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ole Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ole Gerlach more than expected).

Fields of papers citing papers by Lars Ole Gerlach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Ole Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ole Gerlach. The network helps show where Lars Ole Gerlach may publish in the future.

Co-authorship network of co-authors of Lars Ole Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Ole Gerlach. A scholar is included among the top collaborators of Lars Ole Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Ole Gerlach. Lars Ole Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Paroni, Gabriela, Marco Bolis, Adriana Zanetti, et al.. (2018). HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases. Oncogene. 38(15). 2675–2689. 21 indexed citations

Hamre, Harald J., Van N. Pham, Christian Kern, et al.. (2018). A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference. Patient Preference and Adherence. Volume 12. 375–397. 7 indexed citations

Yin, Hang, Lars Ole Gerlach, David T. Moore, et al.. (2006). Arylamide derivatives as allosteric inhibitors of the integrin α2β1/type I collagen interaction. Bioorganic & Medicinal Chemistry Letters. 16(13). 3380–3382. 15 indexed citations

Mathiesen, Jesper Mosolff, Trond Ulven, Lene Martini, et al.. (2005). Identification of Indole Derivatives Exclusively Interfering with a G Protein-Independent Signaling Pathway of the Prostaglandin D2 Receptor CRTH2. Molecular Pharmacology. 68(2). 393–402. 73 indexed citations

Gerlach, Lars Ole, Janus S. Jakobsen, Kasper P. Jensen, et al.. (2002). Metal Ion Enhanced Binding of AMD3100 to Asp²⁶² in the CXCR4 Receptor. Biochemistry. 42(3). 710–717. 114 indexed citations

Gerlach, Lars Ole, Renato T. Skerlj, Gary Bridger, & Thue W. Schwartz. (2001). Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor. Journal of Biological Chemistry. 276(17). 14153–14160. 229 indexed citations

Hansen, Birgit Sehested, Lars Ole Gerlach, A. J. Hansen, Christian Foged, & Peter Henrik Andersen. (2001). The Growth Hormone-Releasing Hormone Receptor: Desensitisation Following Short-Term Agonist Exposure*. Pharmacology & Toxicology. 88(2). 81–88. 4 indexed citations

Gerlach, Lars Ole, et al.. (2001). The Growth Hormone-Releasing Hormone Receptor: Desensitisation Following Short-Term Agonist Exposure*. Pharmacology & Toxicology. 88(2). 81–88. 4 indexed citations

Kunzelmann, Karl, Lars Ole Gerlach, U. Fr�be, & R. Greger. (1991). Bicarbonate permeability of epithelial chloride channels. Pflügers Archiv - European Journal of Physiology. 417(6). 616–621. 32 indexed citations

10.

Greger, R., Karl Kunzelmann, & Lars Ole Gerlach. (1989). Mechanisms of Chloride Transport in Secretory Epithelia^a. Annals of the New York Academy of Sciences. 574(1). 403–415. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact